US2012191079A1PendingUtilityA1

System and method for endoluminal and translumenal therapy

50
Assignee: MOLL FREDERIC HPriority: Jan 20, 2011Filed: Jan 20, 2012Published: Jul 26, 2012
Est. expiryJan 20, 2031(~4.5 yrs left)· nominal 20-yr term from priority
A61B 2018/00577A61B 34/10A61B 2018/0212A61B 2017/00292A61B 5/062A61B 2017/00256A61B 2018/1861A61B 2018/00267A61B 2034/105A61B 34/30A61B 2034/303A61B 2018/00839A61B 5/0066A61B 5/065A61B 2018/00404A61B 1/307A61B 2034/302A61B 5/0084A61B 2018/00285A61B 34/20A61B 2017/00053A61B 2034/2061A61B 18/24A61B 2018/00511A61B 5/14546A61B 18/1492A61B 5/201A61B 2018/00434A61B 5/02007A61B 2090/364A61B 2034/301A61B 2018/1475A61B 2018/00517A61M 25/10A61B 2018/1405A61B 2034/2046
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A system for conducting a denervation of the neural plexus adjacent the renal artery of a patient comprises a first elongate member operatively coupled to a testing element, a second elongate member having a distal portion coupled to an ablative element, and a controller configured to: activate an ablative element to selectively denervate a portion of the neural plexus which is positioned adjacent the ablative element; monitor a level of a compound in blood sampled from the testing element of the first elongate member; and modulate the activation of the ablative element based at least in part upon the level of renin monitored using the testing element.

Claims

exact text as granted — not AI-modified
1 . A system for conducting a denervation of the neural plexus adjacent the renal artery of a patient, comprising:
 a. a first elongate member operatively coupled to a testing element;   b. a second elongate member having a distal portion coupled to an ablative element; and   c. a controller configured to:
 1) activate an ablative element to selectively denervate a portion of the neural plexus which is positioned adjacent the ablative element; 
 2) monitor a level of a compound in blood sampled from the testing element of the first elongate member; and 
 3) modulate the activation of the ablative element based at least in part upon the level of renin monitored using the testing element. 
   
     
     
         2 . The system of  claim 1 , wherein the ablative element is selected from the group consisting of: an RF ablation element, a cryo-ablation element, a laser ablation element, a microwave ablation element and an ultrasound ablation element. 
     
     
         3 . The system of  claim 1 , wherein modulate the activation comprises modulating the energy passed through the ablative element. 
     
     
         4 . The system of  claim 1 , wherein the compound comprises renin. 
     
     
         5 . The system of  claim 1 , wherein the testing element comprises a lumen defined through the first elongate member. 
     
     
         6 . The system of  claim 1 , wherein the first elongate member comprises a distal portion sized to be inserted into the renal vein of the patient. 
     
     
         7 . The system of  claim 1 , wherein the second elongate member comprises an electromechanically steerable catheter having at least one pitch/yaw degree of freedom using one or more motors operatively coupled to the distal portion. 
     
     
         8 . The system of  claim 1 , further comprising an imaging device configured to capture and relay image information to the controller. 
     
     
         9 . The system of  claim 8 , wherein the imaging device is selected from the group consisting of: an ultrasound device, a fluoroscopy device, a radiography device, and an OCT interferometry device. 
     
     
         10 . The system of  claim 8 , wherein the imaging information is used either to identify ablative loci or modulate the activation of the ablative element. 
     
     
         11 . A method for conducting a denervation process upon the neural plexus adjacent the renal artery, comprising:
 a. navigating an ablative element adjacent to a portion of the neural plexus;   b. navigating a testing element into the renal vein;   c. controllably denervating the portion of the neural plexus;   d. utilizing the testing element to detect a compound secreted by a kidney into the renal vein; and   e. determining whether further denervation of the portion of the neural plexus is required based at least in part upon the detection of the compound.   
     
     
         12 . The method of  claim 11 , wherein the ablative element is selected from the group consisting of: an RF ablation element, a cryo-ablation element, a laser ablation element, a microwave ablation element and an ultrasound ablation element. 
     
     
         13 . The method of  claim 11 , wherein the compound comprises renin. 
     
     
         14 . The method of  claim 11 , wherein navigating an ablative element comprises inserting a steerable elongate member coupled to the ablative element relative to the renal artery. 
     
     
         15 . The method of  claim 11 , wherein the testing element comprises a blood sampling lumen, and wherein navigating the testing element comprises inserting an elongate member comprising the testing element relative to the renal vein. 
     
     
         16 . The method of  claim 11 , further comprising imaging targeted portions of the neural plexus to create an anatomic map of the targeted portions. 
     
     
         17 . The method of  claim 16 , wherein imaging utilizes a modality selected from the group consisting of: ultrasound, fluoroscopy, radiography, and OCT interferometry. 
     
     
         18 . The method of  claim 14 , wherein inserting comprises electromechanically inserting the steerable elongate member in response to a command created by an operator with a master input device. 
     
     
         19 . A method for conducting a denervation of the neural plexus adjacent the renal artery, comprising:
 a. creating a neural plexus anatomical map by repeatedly moving, capturing, and assembling image data from an OCT fiber adjacent various portions of the renal artery adjacent the neural plexus;   b. navigating an ablative element adjacent to a targeted portion of the neural plexus that is targeted, at least in part, based upon the neural plexus anatomical map; and   c. controllably denervating the targeted portion of the neural plexus by activating the ablative element.   
     
     
         20 . The method of  claim 19 , wherein the ablative element is selected from the group consisting of: an RF ablation element, a cryo-ablation element, a laser ablation element, a microwave ablation element and an ultrasound ablation element. 
     
     
         21 . The method of  claim 19 , wherein creating a neural plexus anatomical map further comprises conducting interferometry on the captured image data to create one or more images. 
     
     
         22 . The method of  claim 19 , wherein creating a neural plexus anatomical map further comprises placing a distal portion of the OCT fiber immediately adjacent a portion of a wall of the artery. 
     
     
         23 . The method of  claim 19 , wherein assembling image data comprises creating an image based upon image data from various smaller captures of image data. 
     
     
         24 . The method of  claim 19 , wherein repeatedly moving comprises operating an electromechanically steerable elongate member coupled to the OCT fiber. 
     
     
         25 . The method of  claim 19 , wherein navigating an ablative element comprises operating an electromechanically steerable elongate member coupled to the ablative element. 
     
     
         26 . The method of  claim 25 , wherein operating an electromechanically steerable elongate member comprises electromechanically inserting the steerable elongate member in response to a command created by an operator with a master input device. 
     
     
         27 . A system for conducting a denervation of the neural plexus adjacent the renal artery, comprising:
 a. an OCT imaging fiber having a proximal end coupled to an interferometer and a distal end configured to capture image information pertinent to nearby tissue structures;   b. an elongate member configured to be navigated into the renal artery, the elongate member having a distal portion that is coupled to both the distal end of the OCT imaging fiber and an ablative element configured to controllably ablate nearby tissue structures when activated by an operator;   wherein the interferometer is configured to receive signals from the OCT imaging fiber and present images to an operator based at least in part upon the signals, the images being indicative of location and depth of the nearby tissue structures relative to the distal end of the OCT imaging fiber.   
     
     
         28 . The system of  claim 27 , further comprising a lens interposed between the distal end of the OCT imaging fiber and the nearby tissue structures. 
     
     
         29 . The system of  claim 27 , wherein the elongate member is controllably steerable by an operator. 
     
     
         30 . The system of  claim 29 , wherein the elongate member is steerable by an operator in response to operator commands through a master input device. 
     
     
         31 . The system of  claim 30 , wherein the elongate member is operatively coupled to one or more motors configured to controllably induce at least one pitch/yaw degree of freedom. 
     
     
         32 . The system of  claim 27 , further comprising a controller configured to aggregate one or more images from the interferometer into a larger aggregation image. 
     
     
         33 . The system of  claim 27 , further comprising an illumination light source configured to send light through the OCT imaging fiber that may be scattered and received by the OCT imaging fiber to create the image information pertinent to nearby tissue structures.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.